Jennifer Wright

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial

Vivek Subbiah, Jürgen Wolf, Bhavana Konda et al. · The Lancet Oncology · 2022 · 420 citations · Full text

Medicine, Oncology, Endocrine Oncology +13

Molecular Subtypes of<i>KIT/PDGFRA</i>Wild-Type Gastrointestinal Stromal Tumors

Sosipatros A. Boikos, Alberto S. Pappo, J. Keith Killian et al. · JAMA Oncology · 2016 · 407 citations · Full text

Medicine, Oncology, Pathology +17

Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma

Stuart Ibsen, Jennifer Wright, Jean M. Lewis et al. · ACS Nano · 2017 · 387 citations

Medicine, Bioengineering, Biomedical Sciences +17

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas

William D. Tap, Andrew J. Wagner, Patrick Schöffski et al. · JAMA · 2020 · 301 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Phase 3 Trial of Selpercatinib in Advanced <i>RET</i> -Mutant Medullary Thyroid Cancer

Julien Hadoux, Rossella Elisei, Marcia S. Brose et al. · New England Journal of Medicine · 2023 · 190 citations

Medicine, Oncology, Pharmacology +13